In-field Recurrence is Still the Predominant Failure Pattern after Concurrent Chemoradiation Therapy (CCRT) for Cervical Esophageal Squamous Cell Carcinoma

H. Li,X. Fu,J. Liu,C. Lv

DOI: https://doi.org/10.1016/j.ijrobp.2015.07.897

2015-01-01

Abstract:A single arm clinical phase II study to observe failure patterns after CCRT among patients with cervical esophagus squamous cell carcinoma (SCC). All patients were pathologically confirmed with no distant metastasis. All the patients received CCRT followed by consolidate chemotherapy. Elective nodal irradiation was given and platinum-based doublet chemotherapeutic regimens were chosen for both concurrent chemotherapy and consolidate chemotherapy. All patients were followed up every 3 months in the first 2 years after CCRT and every 6 months thereafter. Re-examinations included cervical CT, chest CT, barium esophagram, abdominal CT or B ultrasound, esophagoscopy when necessary. Ninety-two patients were enrolled from March 2007 to July 2014. The median radiation dose was 60 Gy (range: 50-63 Gy). In all the patients, 27 cases (29.3%) received two cycles of concurrent chemotherapy, 68 cases (73.9%) received at least 2 cycles of consolidate chemotherapy. The median follow-up time was 29 months. Patients achieving CR, PR or SD were 61 cases (66.3%), 29 cases (31.5%), 2 cases (2.2%) respectively. One-year, 2-year, and 3-year PFS were: 76.7%, 52.1%, 42.7% (the median PFS: 25 ± 5.316 months). Treatment failures occurred in 38 patients, including 21 cases with locoregional recurrence (LR), 11 cases with distant metastasis, and 6 cases with both failures. Among the patients with LR, in-field recurrence occurred in 21 cases and the median post-progression survival (MPPS) time was 7±1.355 months. For them, 5 cases (24%) were alive after salvage therapy (included radiation therapy and chemotherapy). For the 6 patients without-field LR, the MPPS time was 13±8.764 months. Three of them (50%) were still alive after salvage therapy. One of them has been survived for over 40 months after salvage esophagectomy. Among the 17patients with distant metastasis, pulmonary metastasis occurred in 13 patients (76%). Totally 32 patients were dead. Thirteen patients died of simple LR, 8 patients died of distant metastasis, 6 patients died of both LR and distant metastasis, 1 patient died of stroke, and another four patients died of severe side effects (4.3%), three of them died of had esophageal fistula and another 1 patient died of laryngeal edema. In-field recurrence is still the predominant failure pattern after CCRT for cervical esophageal SCC. Improving in-field local control and reducing distant metastasis may contribute to better efficacy.